FDA Staying The Course Under Ostroff; Hamburg’s Concerns Remain Focus
This article was originally published in The Tan Sheet
Executive Summary
Acting FDA Commissioner Ostroff says he does not envision new major priorities that would emerge in the short-term. The former FDA chief scientist is non-committal about submitting his name as a candidate for permanent commissioner.